QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Read More
The need for quick H1N1 assays further propels molecular to the forefront.
Read MoreComplete Genomics Inc, a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009
Read MoreAMDL Inc announces the inauguration of AMDL Diagnostics Inc (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-SureAMDL’s proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.
Read More
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences Laboratory Corp of America® Holdings (LabCorp) and Monogram Biosciences Inc announced recently that they have entered into a definitive agreement and plan of merger under which
Read More